Aspergillus and progression of lung disease in children with cystic fibrosis

Sabariah Noor Harun; Claire E Wainwright; Keith Grimwood; Stefanie Hennig; Joyce Cheney; Narelle George; Colin F Robertson; Rosemary Carzino; Marj Moodie; David S Armstrong; Peter J Cooper; A James Martin; Bruce Whitehead; Catherine A Byrnes; Harm A Tiddens; Nicholas Gailer; Katrina Jess; Peta Yarrow; Merilyn McArthur; Sam Forbes; Hiran Selvadurai; John Massie; Sarath Ranganathan; Phil Robinson; Jan Tate; Els Van der Wiel

Journal article

Aspergillus and progression of lung disease in children with cystic fibrosis

Sabariah Noor Harun, Claire E Wainwright, Keith Grimwood, Stefanie Hennig, Joyce Cheney, Narelle George, Colin F Robertson, Rosemary Carzino, Marj Moodie, David S Armstrong, Peter J Cooper, A James Martin, Bruce Whitehead, Catherine A Byrnes, Harm A Tiddens, Nicholas Gailer, Katrina Jess, Peta Yarrow, Merilyn McArthur, Sam Forbes Show all

Thorax | BMJ PUBLISHING GROUP | Published : 2019

DOI: 10.1136/thoraxjnl-2018-211550

University of Melbourne Researchers

Sarath Ranganathan Author Paediatrics Royal Children's Hospital

Colin Robertson Author Paediatrics Royal Children's Hospital

Grants

Awarded by National Health and Medical Research Council

Funding Acknowledgements

The original AC FBAL study was supported by the National Health and Medical Research Council (grants 9937868 and 351541) and the Children's Hospital Foundation Queensland, Australia. The tobramycin inhalation solution and delivery system used throughout the AC FBAL study was supplied by Pathogenesis Corporation, Chiron Corporation and Novartis Pharmaceuticals Inc.